ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION

Clinical trials for ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION explained in plain language.

Never miss a new study

Get alerted when new ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION trials appear

Sign up with your email to follow new studies for ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New drug combo tested for Tough-to-Treat leukemia

Disease control Ongoing

This study is testing a combination of intensive chemotherapy (called Hyper-CVAD) and a targeted drug called ponatinib for adults with a specific type of acute lymphoblastic leukemia (ALL) that involves a genetic change called Philadelphia chromosome or BCR-ABL. The main goal is …

Matched conditions: ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION

Get alerted when new ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION trials appear

New drug combo tested for Tough-to-Treat leukemia